| RS2146420485 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2146420510 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146420554 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146420616 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146420831 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146421085 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146421194 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146421305 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146421348 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146421585 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2146421764 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, Hearing impairment |
| RS2146422618 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146422656 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146423140 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146423728 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146424948 |
PRPF31
|
Health Risk |
Likely pathogenic |
— |
| RS2146425748 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146425937 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146426154 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146427112 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146427417 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146427557 |
NLRP2
|
Health Risk |
risk factor |
Multisystem inflammatory syndrome in children, Multisystem inflammatory syndrome in children |
| RS2146427772 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146427913 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146428203 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146428393 |
ARL2BP
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa with or without situs inversus, Retinitis pigmentosa with or without situs inversus |
| RS2146430397 |
ARL2BP
|
Health Risk |
Likely pathogenic |
— |
| RS2146430688 |
TMPRSS3
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS2146434180 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2146436212 |
TMPRSS3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS2146436261 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146436400 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146436807 |
PDGFB
|
Health Risk |
Pathogenic |
— |
| RS2146436884 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146437002 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146438016 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2146438052 |
HNF4A
|
Health Risk |
Likely pathogenic |
— |
| RS2146439342 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2146440365 |
KMT2B
|
Health Risk |
Likely pathogenic |
KMT2B-related disorder, KMT2B-related disorder |
| RS2146443608 |
PRPF31
|
Health Risk |
Likely pathogenic |
— |
| RS2146444340 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146445593 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2146445734 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146445759 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146445800 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146445865 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2146446330 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2146448317 |
TMPRSS3
|
Health Risk |
Pathogenic |
— |
| RS2146448409 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2146448773 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2146449761 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146449768 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146449804 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146449862 |
PRPF31;PRPF31-AS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 11 |
| RS2146449983 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146450050 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146450161 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146450184 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146450721 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146451944 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146452391 |
TMPRSS3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS2146452576 |
TMPRSS3
|
Health Risk |
Pathogenic |
— |
| RS2146453060 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146454464 |
MIB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146455000 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2146455415 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146455513 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS2146458114 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2146459243 |
PDGFB
|
Health Risk |
Pathogenic |
— |
| RS2146459766 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Dystonia 28 |
| RS2146461810 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2146462970 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2146464332 |
NAA20
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 73 |
| RS2146467115 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2146467548 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2146468685 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2146468805 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2146469485 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonic disorder, Dystonic disorder |
| RS2146470550 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2146471012 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146471495 |
SIK1
|
Health Risk |
Likely pathogenic |
— |
| RS2146471651 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146472496 |
ITCH
|
Health Risk |
Likely pathogenic |
— |
| RS2146473230 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2146473376 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146474333 |
SMARCA4
|
Health Risk |
Pathogenic |
— |
| RS2146474742 |
MIB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146475644 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146479981 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2146481256 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2146481783 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2146482963 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2146483064 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2146483253 |
RFXANK
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2146486142 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146489987 |
CYP24A1
|
Health Risk |
Likely pathogenic |
Hypercalcemia, infantile |
| RS2146492780 |
RFXANK
|
Health Risk |
Pathogenic/Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2146493181 |
RFXANK
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2146496053 |
RFXANK
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2146496372 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |